BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dupixent Discussions - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dupixent Discussions
X-ORIGINAL-URL:https://www.dupixentdiscussions.com
X-WR-CALDESC:Events for Dupixent Discussions
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251020T121500
DTEND;TZID=America/Chicago:20251020T131500
DTSTAMP:20260408T105422
CREATED:20250829T203309Z
LAST-MODIFIED:20250919T211348Z
UID:10000726-1760962500-1760966100@www.dupixentdiscussions.com
SUMMARY:DUPIXENT® (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Dareen Siri\, MD
DESCRIPTION:Join us for a virtual discussion with an expert speaker and a caregiver of a pediatric patient with atopic dermatitis (AD) to learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation[gravityform id=”1″ field_values=”zoomid=91691990582″]
URL:https://www.dupixentdiscussions.com/event/dupixent%c2%a8-dupilumab-patient-story-followed-by-a-treatment-option-for-appropriate-patients-with-certain-skin-diseases-driven-in-part-by-type-2-inflammation-by-dareen-siri-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Atopic Dermatitis (AD)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/04/Dareen-Siri-MD.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251016T121500
DTEND;TZID=America/Chicago:20251016T131500
DTSTAMP:20260408T105422
CREATED:20250829T203308Z
LAST-MODIFIED:20250926T004057Z
UID:10000725-1760616900-1760620500@www.dupixentdiscussions.com
SUMMARY:Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age   by Dareen Siri\, MD
DESCRIPTION:Join us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation. [gravityform id=”1″ field_values=”zoomid=93788306547″]
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-dareen-siri-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Atopic Dermatitis (AD)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/04/Dareen-Siri-MD.png
END:VEVENT
END:VCALENDAR